VIR — Vir Biotechnology, Inc. stock price, charts and financials

QT53Vir Biotechnology, Inc.

Vir Biotechnology, Inc. (NASDAQ: VIR) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
9.17
+0.27+3.03%
OverviewShort InterestFilings
VIRQT53Vir Biotechnology, Inc.·NASDAQ
9.17+3.03%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Jul 31, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 24, 20268-KCurrent report
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20268-KCurrent report
Jun 10, 20263Initial statement of beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
Jun 02, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 28, 20264Statement of changes in beneficial ownership
May 28, 20268-KCurrent report
May 15, 2026SC 13G/ABeneficial ownership statement (passive, amended)
May 07, 202610-QQuarterly report
May 06, 20268-KCurrent report
May 04, 20264Statement of changes in beneficial ownership
Apr 30, 20264Statement of changes in beneficial ownership
Apr 29, 2026SC 13GBeneficial ownership statement (passive)
Apr 16, 2026DEFA14AAdditional proxy soliciting materials
Apr 16, 2026DEF 14ADefinitive proxy statement
Apr 16, 2026ARSAnnual report to shareholders
Apr 10, 20268-KCurrent report
Apr 07, 20264Statement of changes in beneficial ownership
#1 / 25 of 444
Page
▼
/ 18